Nucleic acid amplification testing for Neisseria gonorrhoeae: An ongoing challenge

Journal of Molecular Diagnostics

Volumn 8, Issue 1, 2006, Pages 3-15

  Whiley, David M ^a,b   Tapsall, John W ^c   Sloots, Theo P ^a,b,d  

^a Royal Children's Hospital and Health Service District   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c New South Wales Government   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; COMMENSALISM; COMPETITIVE INHIBITION; COST BENEFIT ANALYSIS; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FALSE POSITIVE RESULT; GENE TARGETING; GENE TRANSFER; GENETIC VARIABILITY; GENUS; GONORRHEA; HUMAN; INTERMETHOD COMPARISON; MEDICAL EDUCATION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; REVIEW;

BACTERIA (MICROORGANISMS); NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 32944465964     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050045     Document Type: Review

References (105)

1. Gerbase AC, Rowley JT, Heymann DHL, Berkley SFB, Piot P: Global prevalence and incidence estimates of selected curable STDs. Sex Transm Inf 1998, 74:S12-S16
2. Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, 2003. Atlanta, GA, U.S. Department of Health and Human Services, CDC, 2003
3. Biro FM, Rosenthal SL, Kiniyalocts M: Gonococcal and chlamydial genitourinary infections in symptomatic and asymptomatic adolescent women. Clin Pediatr (Phila) 1995, 34:419-423
4. Tapsall J: Antibiotic Resistance in Neisseria gonorrhoeae. WHO/CDS/CSR/DRS/2001.3. Geneva, World Health Organization, 2001
5. Brunham RC, Plummer FA, Stephens RS: Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun 1993, 61:2273-2276
6. O'Rourke M, Stevens E: Genetic structure of Neisseria gonorrhoeae populations: a non-clonal pathogen. J Gen Microbiol 1993, 139:2603-2611
7. Kline KA, Sechman EV, Skaar EP, Seifert HS: Recombination, repair and replication in the pathogenic Neisseria: the 3 R's of molecular genetics of two human-specific bacterial pathogens. Mol Microbiol 2003, 50:3-13
8. Peeling RW, Mabey DCW, Holmes KK: Molecular techniques for HIV and STDs: implications for research and disease control in the new millenium. Methods in Molecular Medicine: Sexually Transmitted Diseases Methods and Protocols. Edited by RW Peeling, PF Sparling. Totowa, NJ, Humana Press, 1999, pp. 219-231
9. Miller PJ, Torzillo PJ, Hateley W: Impact of improved diagnosis and treatment on prevalence of gonorrhoea and chlamydial infection in remote aboriginal communities on Anangu Pitjantjatjara Lands. Med J Aust 1999, 170:429-432
10. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM: Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections: 2002. MMWR Recomm Rep 2002, 18:1-38
11. Koumans EH, Johnson RE, Knapp JS, St. Louis ME: Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 1998, 27:1171-1180
12. Thomason JL, Gelbart SM, Sobieski VJ, Anderson RJ, Schulien MB, Hamilton PR: Effectiveness of Gonozyme for detection of gonorrhea in low-risk pregnant and gynecologic populations. Sex Transm Dis 1989, 16:28-31
13. Chapin-Robertson K, Reece EA, Edberg SC: Evaluation of the Gen-Probe PACE II assay for the direct detection of Neisseria gonorrhoeae in endocervical specimens. Diagn Microbiol Infect Dis 1992, 15:645-649
14. Modarress KJ, Cullen AP, Jaffurs WJ Sr, Troutman GL, Mousavi N, Hubbard RA, Henderson S, Lorincz AT: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in swab specimens by the Hybrid Capture II and PACE 2 nucleic acid probe tests. Sex Transm Dis 1999, 26:303-308
15. Beltrami JF, Farley TA, Hamrick JT, Cohen DA, Martin DH: Evaluation of the Gen-Probe PACE 2 assay for the detection of asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in male arrestees. Sex Transm Dis 1998, 25:501-504
16. Schachter J, Hook EW III, McCormack WM, Quinn TC, Chernesky M, Chong S, Girdner JI, Dixon PB, DeMeo L, Williams E, Cullen A, Lorincz A: Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol 1999, 37:3668-3671
17. Centers for Disease Control and Prevention: Notice to readers: recall of LCx Neisseria gonorrhoeae assay and implications for laboratory testing for N. gonorrhoeae and Chlamydia trachomatis. MMWR Morb Mortal Wkly Rep 2002, 51:709
18. Bassiri M, Mardh PA, Domeika M: Multiplex AMPLICOR PCR screening for Chlamydia trachomatis and Neisseria gonorrhoeae in women attending non-sexually transmitted disease clinics: The European Chlamydia Epidemiology Group. J Clin Microbiol 1997, 35:2556-2560
19. Caldwell JG, Price EV, Pazin GJ, Cornelius CE III: Sensitivity and reproducibility of Thayer-Martin culture medium in diagnosing gonorrhea in women. Am J Obstet Gynecol 1971, 109:463-468
20. Schmale JD, Martin JE Jr, Domescik G: Observations on the culture diagnosis of gonorrhea in women. JAMA 1969, 210:312-314
21. Garrow SC, Smith DW, Harnett GB: The diagnosis of chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice. Sex Transm Infect 2002, 78:278-281
22. Mahony J, Chong S, Jang D, Luinstra K, Faught M, Dalby D, Sellors J, Chernesky M: Urine specimens from pregnant and non-pregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998, 36:3122-3126
23. Chan EL, Brandt K, Olienus K, Antonishyn N, Horsman GB: Performance characteristics of the Becton Dickinson ProbeTec System for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine specimens in comparison with the Roche Cobas System. Arch Pathol Lab Med 2000, 124:1649-1652
24. Toye B, Woods W, Bobrowska M, Ramotar K: Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J Clin Microbiol 1988, 36:2356-2358
25. Verkooyen RP, Luijendijk A, Huisman WM, Goessens WH, Kluytmans JA, van Rijsoort-Vos JH: Detection of PCR inhibitors in cervical specimens by using the Amplicor Chlamydia trachomatis assay. J Clin Microbiol 1996, 34:3072-3074
26. Hoorfar J, Cook N, Malorny B, Wagner M, De Medici D, Abdulmawjood A, Fach P: Making internal amplification control mandatory for diagnostic PCR. J Clin Microbiol 2003, 41:5835
27. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J: Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003, 41:304-309
28. Hamilton MS, Otto M, Nickell A, Abel D, Ballam Y, Schremmer R: High frequency of competitive inhibition in the Roche Cobas AMPLICOR multiplex PCR for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2002, 40:4393
29. Kacena KA, Quinn SB, Hartman SC, Quinn TC, Gaydos CA: Pooling of urine samples for screening for Neisseria gonorrhoeae by ligase chain reaction: accuracy and application. J Clin Microbiol 1998, 36:3624-3628
30. Kissin DM, Holman S, Minkoff HL, DeMeo L, McCormack WM, DeHovitz JA: Epidemiology and natural history of ligase chain reaction detected chlamydial and gonococcal infections. Sex Transm Infect 2002, 78:208-209
31. Currie MJ, McNiven M, Yee T, Schiemer U, Bowden FJ: Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving. J Clin Microbiol 2004, 42:4866-4867
32. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA: Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998, 36:481-485
33. Krepel J, Patel J, Sproston A, Hopkins F, Jang D, Mahony J, Chernesky M: The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections. Sex Transm Dis 1999, 26:504-507
34. Morre SA, Meijer CJ, Munk C, Kruger-Kjaer S, Winther JF, Jorgensens HO, van Den Brule AJ: Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs. J Clin Microbiol 2000, 38:1679-1680
35. Peeling RW, Toye B, Jessamine P, Gemmill I: Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 1998, 74:66-70
36. Bang D, Angelso L, Schirakow B, Westh H: Comparison of the Becton Dickinson strand displacement amplification and Cobas Amplicor Roche PCR for the detection of Chlamydia trachomatis: pooling versus individual tests. Clin Microbiol Infect 2003, 9:1020-1023
37. Burkardt HJ: Standardization and quality control of PCR analyses. Clin Chem Lab Med 2000, 38:87-91
38. Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols T, Livermore DM, GRASP collaboration: Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet 2003, 361:1867-1869
39. Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y: Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2002, 46:3744-3749
40. Li Z, Yokoi S, Kawamura Y, Maeda S, Ezaki T, Deguchi T: Rapid detection of quinolone resistance-associated gyrA mutations in Neisseria gonorrhoeae with a LightCycler. J Infect Chemother 2002, 8:145-150
41. World Health Organization. Management of Sexually Transmitted Diseases. WHO/GPA/TEM94.1 Rev 1. Geneva, World Health Organization, 1997
42. Tapsall J, Members of the National Neisseria Network of Australia: Antimicrobial testing and applications in the pathogenic Neisseria. Antimicrobial Susceptibility Testing: Methods and Practices with an Australian Perspective. Edited by J Merlino. Sydney, Australia, Australian Society for Microbiology, 2004, pp. 175-188
43. Young H, Manavi K, McMillan A: Evaluation of ligase chain reaction for the non-cultural detection of rectal and pharyngeal gonorrhoea in men who have sex with men. Sex Transm Infect 2003, 79:484-486
44. Tapsall J: How the biology of Neisseria gonorrhoeae impinges upon laboratory contributions to control of gonococcal disease [Abstract]. Program and Abstracts of the 2004 National Conference of the Australian Society for Microbiology International, 2004
45. Bachmann LH, Desmond RA, Stephens J, Hughes A, Hook EW III: Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea. J Clin Microbiol 2002, 40:3596-3601
46. Ison CA, Whitaker L, Renton A: Concordance of auxotype/serovar classes of Neisseria gonorrhoeae between sexual contacts. Epidemiol Infect 1992, 109:265-271
47. Sarafian SK, Knapp JS: Molecular epidemiology of gonorrhea. Clin Microbiol Rev 1989, 2:S49-S55
48. Wang SP, Holmes KK, Knapp JS, Ott S, Kyzer DD: Immunologic classification of Neisseria gonorrhoeae with micro-immunofluorescence. J Immunol 1977, 119:795-803
49. Palmer HM, Mallinson H, Wood RL, Herring AJ: Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J Clin Microbiol 2003, 41:835-837
50. Bruisten SM, Noordhoek GT, van den Brule AJ, Duim B, Boel CH, El-Faouzi K, du Maine R, Mulder S, Luijt D, Schirm J: Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrhoeae. J Clin Microbiol 2004, 42:4332-4334
51. Tabrizi SN, Chen S, Cohenford MA, Lentrichia BB, Coffman E, Shultz T, Tapsall JW, Garland SM: Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect 2004, 80:68-71
52. Lum G, Freeman K, Nguyen NL, Limnios EA, Tabrizi SN, Carter I, Chambers IW, Sloots TP, Garland SM, Tapsall JW: A cluster of gonococcal infections positive on culture but with negative cppB gene based nucleic acid amplification assays. Sex Transm Infect, 2005, 81:400-402
53. Tapsall J, Limnios A, Carter I, Lum G, Freeman K, Sloots T: A cluster of culture-positive, but PCR false negative infections with Neisseria gonorrhoeae [abstract]. Program and Abstracts of the 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research (ISSTDR), 27-30 July 2003; Ottawa, ON, Canada. 2003, 0129
54. Ching S, Lee H, Hook EW III, Jacobs MR, Zenilman J: Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol 1995, 33:3111-3114
55. Leslie DE, Azzato F, Ryan N, Fyfe J: An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types. Commun Dis Intell 2003, 27:373-379
56. Van Der Pol B, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, Jungkind D, Martin DH, Turner B, Peyton C, Jones RB: Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol 2000, 38:1105-1112
57. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 2001, 39:1751-1756
58. Feavers IM, Maiden MC: A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol Microbiol 1998, 30:647-656
59. Vazquez JA, De La Fuente L, Berron S, O'Rourke M, Smith NH, Zhou J, Spratt BG: Ecological separation and genetic isolation of Neisseria gonorrhoeae and Neisseria meningitidis. Curr Biol 1993, 3:567-572
60. Frosch M, Meyer TF: Transformation-mediated exchange of virulence determinants by co-cultivation of pathogenic Neisseriae. FEMS Microbiol Lett 1992, 79:345-349
61. Gibbs CP, Meyer TF: Genome plasticity in Neisseria gonorrhoeae. FEMS Microbiol Lett 1996, 145:173-179
62. Linz B, Schenker M, Zhu P, Achtman M: Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol 2000, 36:1049-1058
63. Smith NH, Holmes EC, Donovan GM, Carpenter GA, Spratt BG: Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol 1999, 16:773-783
64. Farrell DJ: Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J Clin Microbiol 1999, 37:386-390
65. Whiley DM, Sloots TP: A new Neisseria gonorrhoeae PCR assay [abstract]. Roche LightCycler User Group Meeting 2-4 November 2004; Mt. Wellington, New Zealand, 2004, 9.30
66. Young H, Reid KG: Immunological diagnosis of gonococcal infection. Immunological Diagnosis of Sexually Transmitted Diseases: Clinical and Biochemical Analysis, vol 23. Edited by H Young, A McMillan. New York, Marcel Dekker, 1988, pp. 77-116
67. Knapp J, Rice RJ: Neisseria and Branhamella. Manual of Clinical Microbiology. Edited by PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken. Washington, DC, ASM Press, 1995, pp. 324-340
68. Hammerschlag MR: Appropriate use of nonculture tests for the detection of sexually transmitted diseases in children and adolescents. Semin Pediatr Infect Dis 2003, 14:54-59
69. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2002. MMWR Recomm Rep 2002, 51:67-69
70. Katz AR, Effler PV, Ohye RG, Brouillet B, Lee MV, Whiticar PM: False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis 2004, 38:814-819
71. Klausner JD: The NAAT is out of the bag. Clin Infect Dis 2004, 38:820-821
72. Diemert DJ, Libman MD, Lebel P: Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population. J Clin Microbiol 2002, 40:4056-4059
73. Green TA, Black CM, Johnson RE: Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis. J Clin Microbiol 1998, 36:375-381
74. Hadgu A: Discrepant analysis is an inappropriate and unscientific method. J Clin Microbiol 2000, 38:4301-4302
75. Martin DH, Cammarata C, Van Der Pol B, Jones RB, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, Jungkind D, Turner B, Peyton C: Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol 2000, 38:3544-3549
76. Moncada J, Schachter J, Hook EW III, Ferrero D, Gaydos C, Quinn TC, Willis D, Weissfeld A, Martin DH: The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis 2004, 31:273-277
77. Turner A, Gough KR, Jephcott AE: Comparison of three methods for culture confirmation of Neisseria gonorrhoeae strains currently circulating in the UK. J Clin Pathol 1995, 48:919-923
78. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD: Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 2002, 34:173-176
79. Stary A, Ching SF, Teodorowicz L, Lee H: Comparison of ligase chain reaction and culture for detection of Neisseria gonorrhoeae in genital and extragenital specimens. J Clin Microbiol 1997, 35:239-242
80. Whiley DM, Buda PJ, Freeman K, Pattle NI, Bates J, Sloots TP: A real-time PCR assay for the detection of Neisseria gonorrhoeae in genital and extragenital specimens. Diagn Microbiol Infect Dis 2005 52:1-5
81. Schwarcz SK, Kellogg TA, Kohn RP, Katz MH, Lemp GF, Bolan GA. Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am J Epidemiol 1995, 142:314-322
82. Centers for Disease Control and Prevention: Increases in unsafe sex and rectal gonorrhea among men who have sex with men: San Francisco, 1994-1997. MMWR Morb Mortal Wkly Rep 1999, 48:45-48
83. Hutt DM, Judson FN: Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med 1986, 104:655-658
84. Jebakumar SPR, Storey C, Lusher M, Nelson J, Goorney B, Haye KR: Value of screening for oro-pharyngeal Chlamydia trachomatis infection. J Clin Pathol 1995, 48:658-661
85. Lafferty WE, Hughes JP, Handsfield HH: Sexually transmitted diseases in men who have sex with men: acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997, 24:272-278
86. Tice A, Rodriguez V. Pharyngeal gonorrhea. JAMA 1981, 246:2717-2719
87. Wiesner PJ, Tronca E, Bonin P, Pedersen AH, Holmes KK: Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med 1973, 288:181-185
88. Farrell DJ, Sheedy TJ: Urinary screening for Neisseria gonorrhoeae in asymptomatic individuals from Queensland, Australia: an evaluation using three nucleic acid amplification methods. Pathology 2001, 33:204-205
89. van Doornum GJ, Schouls LM, Pijl A, Cairo I, Buimer M, Bruisten S: Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol 2001, 39:829-835
90. Whiley DM, LeCornec GM, Mackay IM, Siebert DJ, Sloots TP: A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler. Diagn Microbiol Infect Dis 2002, 42:85-89
91. Whiley DM, Buda PJ, Bayliss J, Cover L, Bates J, Sloots TP: A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis 2004, 23:705-710
92. Unemo M, Norlen O, Fredlund H: The porA pseudogene of Neisseria gonorrhoeae: genetic polymorphism and inactivating mutations. Program and Abstracts of the 14th International Pathogenic Neisseria Conference (IPNC), 5-10 September 2004; Milwaukee, WI, 2004, 318
93. Koenig MG, Kosha SL, Doty BL, Heath DG: Direct comparison of the BD ProbeTec ET system with in-house LightCycler PCR assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae from clinical specimens. J Clin Microbiol 2004, 42:5751-5756
94. Braverman PK, Schwarz DF, Mph M, Deforest A, Hodinka RL, McGowan KL, Mortensen JE: Use of ligase chain reaction for laboratory identification of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent women. J Pediatr Adolesc Gynecol 2002, 15:37-41
95. Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S: Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998, 36:1630-1633
96. Kehl SC, Georgakas K, Swain GR, Sedmak G, Gradus S, Singh A, Foldy S: Evaluation of the Abbott LCx assay for detection of Neisseria gonorrhoeae in endocervical swab specimens from females. J Clin Microbiol 1998, 36:3549-3551
97. Smith KR, Ching S, Lee H, Ohhashi Y, Hu HY, Fisher HC III, Hook EW III: Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol 1995, 33:455-457
98. Xu K, Glanton V, Johnson SR, Beck-Sague C, Bhullar V, Candal DH, Pettus KS, Farshy CE, Black CM: Detection of Neisseria gonorrhoeae infection by ligase chain reaction testing of urine among adolescent women with and without Chlamydia trachomatis infection. Sex Transm Dis 1998, 25:533-538
99. Golden MR, Hughes JP, Cles LE, Crouse K, Gudgel K, Hu J, Swenson PD, Stamm WE, Handsfield HH: Positive predictive value of Gen-Probe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection. Clin Infect Dis 2004, 39:1387-1390
100. Boyadzhyan B, Yashina T, Yatabe JH, Patnaik M, Hill CS: Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2004, 42:3089-3093
101. Chaudhry U, Saluja D: Detection of Neisseria gonorrhoeae by PCR using orf1 gene as target. Sex Transm Infect 2002, 78:72
102. Liebling MR, Arkfeld DG, Michelini GA, Nishio MJ, Eng BJ, Jin T, Louie JS: Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum 1994, 37:702-709
103. Tabrizi SN, Chen S, Tapsall J, Garland SM: Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae. Sex Transm Dis 2005, 32:199-202
104. Livengood CH III, Wrenn JW: Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens. J Clin Microbiol 2001, 39:2928-2932
105. Little MC, Andrews J, Moore R, Bustos S, Jones L, Embres C, Durmowicz G, Harris J, Berger D, Yanson K, Rostkowski C, Yursis D, Price J, Fort T, Walters A, Collis M, Llorin O, Wood J, Failing F, O'Keefe C, Scrivens B, Pope B, Hansen T, Marino K, Williams K, Boenisch M: Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem 1999, 45:777-7784